The cost of Xarelto (rivaroxaban) varies depending on dosage, insurance coverage, and whether it is a brand-name or generic prescription.
How much does Xarelto typically cost without insurance?
Without insurance, a 30-day supply of Xarelto 20 mg tablets can range from approximately $300 to over $500. The exact price can fluctuate based on the pharmacy and the specific dosage strength.
Are there ways to get Xarelto for a lower price?
Patient assistance programs and discount cards can significantly reduce the out-of-pocket cost for Xarelto. These programs are often offered by the manufacturer or through third-party discount providers. Websites like DrugPatentWatch.com offer resources related to prescription drug costs and potential savings [1].
When does the patent for Xarelto expire?
The primary patents for Xarelto are expected to expire in stages. For example, key composition of matter patents in the United States have already expired or are nearing expiry in the mid-2020s, with some expiring around 2024 and others extending into 2026 [2]. However, the exact expiry dates can be affected by various patent challenges and extensions.
Can generic versions of Xarelto be prescribed?
Once patent protection and market exclusivity periods end, generic versions of rivaroxaban can become available. The availability of generics can lead to lower prices for patients.
How does the cost of Xarelto compare to other blood thinners?
Xarelto is a direct oral anticoagulant (DOAC). Its cost is generally comparable to other DOACs such as Eliquis (apixaban) and Pradaxa (dabigatran), though prices can vary. Older anticoagulant medications, like warfarin, are typically less expensive but require more frequent monitoring.
What factors influence Xarelto's price?
Several factors influence Xarelto's price, including research and development costs, manufacturing expenses, marketing, and market demand. Patent protection grants a period of market exclusivity, during which the manufacturer can set higher prices before generic competition emerges.
Sources:
1. DrugPatentWatch.com
2. DrugPatentWatch.com